Apr 27, 2026

Featuring perspectives from Dr Suresh S Ramalingam and Dr Helena Yu, including the following topics:

• Introduction: Genomics of EGFR (and HER2) (0:00)
• Metastatic Disease (9:30)
• Localized Disease (30:22)
• EGFR Exon 20 Insertion Mutations (46:57)
• New Agents (54:20)

CME information and select...

Apr 27, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer | Faculty Presentation 2: Other Relevant Topics in EGFR-Mutant NSCLC (eg, Nonmetastatic Disease, Exon 20 Insertion Mutations, Novel Agents) — Suresh S Ramalingam, MD

Apr 27, 2026

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in EGFR-Mutant Non-Small Cell Lung Cancer | Faculty Presentation 1: Management of Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) — Helena Yu, MD

CME information and select...

Apr 17, 2026

Featuring an interview with Dr Natalie Vokes, including the following topics:

• Perioperative minimal residual disease (MRD) detected by circulating tumor DNA (ctDNA) testing in patients with lung cancer (0:00)
  • Ohara S et al. Clinical significance of perioperative MRD detected by ctDNA in patients with lung...

Feb 27, 2026

Featuring perspectives from Dr Luis Paz-Ares and Dr Misty Dawn Shields, including the following topics:

• Introduction: Rational Treatment Goals for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)? (0:00)
• Current Considerations in the Selection of First-Line and Maintenance Therapy — Dr Borghaei (8:13)
• Case: A woman...